There was a trend towards inferior scores in patients with previous exposure to ipilimumab but this did not reach statistical significance ( Fig. 2 ) .
← all excerpts
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors.
1
—
—